chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Numbness of the left side of the face and headache on the left side and part of the tongue; Numbness of the left side of the face and headache on the left side and part of the tongue; The left side of my body, like burning (ankle, elbow); The left side of my body, like burning (ankle, elbow); This is a spontaneous report from a contactable healthcare professional (patient). A 65-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), intramuscular at left arm on 30Dec2020 11:30 at SINGLE DOSE for COVID-19 immunization. Medical history included known allergies to Uva roja. The patient is not pregnant. No COVID prior vaccination. Facility where the most recent COVID-19 vaccine was administered was in the Doctor's office/urgent care. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications (received within 2 weeks of vaccination) included atorvastatin (LIPITOR) and fexofenadine hydrochloride (ALLEGRA). The patient previously took titanium and experienced allergies. On 30Dec2020 , the patient experienced numbness of the left side of the face and headache on the left side and part of the tongue. The left side of patient's body, like burning (ankle, elbow). No treatment received for the events. The events were assessed as non-serious. The patient had not been tested for COVID post vaccination. The outcome of the events was recovered on unspecified date.  Information on lot/batch number has been requested.
After having the shot I complained about my upper arm constricted stared swelling, I was told that was normal?? it would be better the next day!! I was in a detox unit @ hospital, the next morning my upper arm swelled bigger then I ever seen it also I had a huge abscess on my elbow!! and the infection was on the move..after a few more hours it spead down my arm the "swelling" I taking by ambulance to the medical center. I was told I had a severe infection in my arm??? I was admitted from the E.R. and spent 4th, 5th 6th of March 2008 hospitalized!! OH sorry lol for got the name of the vaccine was  PNEUMOVAX 23 me/showed me a pamphlet saying only less then 1 percent have allergic reacations??? I GOT INFECTED!!!!!!! How can I find out who is the manufactuter??? 4/7/08-records received for DOS 3/4-3/6/08-DC DX: Cellulitis left upper extremity. Olecranon bursitis. C/O worsening swelling and redness after pneumococcal vaccine 2 days prior to admission. Low grade fever. Erythema over left elbow and left forearm.  Follow-up: To whom it may concern: I recently sent you a form about "getting infected" after receiving a vaccine for pneumonia 23. I tried saving the form as is, filled out, before sending it to you, so I hope that you received it properly filled out?? Can you please send me a copy back? via e-mail, and i was also wondering if you knew who the manufacture is for this vaccine?? Pneumococcal Polysaccharide thank you for your help.
Awakened with vertigo which has progressed and at times severe. Still persists. Was normotensive; BP now 140-150/90-100
Initial information received on 19-Oct-2018 regarding an unsolicited valid non-serious case received from Practitioner. This case involves patient of an unknown demographics who received vaccine FLUZONE QUADRIVALENT lot number not reported (dose, expiry date, route and site of administration were unknown). The patient's past medical history included Heart transplant. The patient's past medical treatment(s), vaccination(s) and family history were not provided. It was a case of Drug interaction. It was reported that the patient has had a heart transplant and is taking an anti-rejection drug (immunosuppressive therapy). Other relevant tests included no lab data. It was not reported if the patient received a corrective treatment. Documents held by sender: none.
Vaccine administered from a vial that has possibly been punctured for 48 hours.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered from a vial that has possibly been punctured for 48 hours.) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Aug-2021 at 9:40 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered from a vial that has possibly been punctured for 48 hours.). On 25-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered from a vial that has possibly been punctured for 48 hours.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medication information was reported. No treatment medications were reported.  The patient given dose was punctured before 96 hours of administration.   Most recent FOLLOW-UP information incorporated above includes: On 29-Aug-2021: Follow-up received added Patient demographics, updated event outcome.
Palmar digital vein thrombosis on my left index finger of the second digit; This is a spontaneous report from a contactable consumer (patient). This 58-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0173) via an unspecified route of administration on 05May2021 at 08:30 (at the age of 58-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included high blood pressure and allergy to pollen. The patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications included amlodipine from an unknown date for an unknown indication. On 12May2021 the patient experienced palmar digital vein thrombosis on her left index finger of the second digit. The event was reported as non-serious. The patient was not hospitalized for the event. The patient visited a doctor or other healthcare professional office/clinic as a result of the event. The patient did not receive treatment for the event. The outcome of palmar digital vein thrombosis was not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.
Information had been received from a certified medical assistant concerning a 79 year old female with chronic obstructive pulmonary disease and chronic respiratory acidosis, who on 8/1/05 at 15:00 was vaccinated IM into the left arm with a second dose of Pneumococcal 23v polysaccharide vaccine lot 649694/0386P. On 8/2/05, the patient experienced a local site reaction of redness, tenderness and edema. The pt stated that her arm was sore, she had some swelling and had a low grade fever. That day the pt was brought in for a follow up appt. The Dr noted erythema in the left arm that measured 16cm in length and 16 cm in width. The DR also noted that it looked like skin cellulitis. Subsequently the pt recovered. The medical assistant requested a lot check. No product quality complaint was involved. The records of testing prior to release of this lot have been checked and found to be satisfactory. The lot complies with the standards and was released.
I had a very low grade fever off and on. It went up to about 101, but then it stopped. I had body aches and nauseas. I thought I was going to vomit at one point but I didn't.
This spontaneous report was received from a healthcare professional referring to unspecified patient of unknown age or gender. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patients were vaccinated with 2 improperly stored doses of GARDASIL (dose, anatomical location or frequency were unknown) lot # K004205, expiration date: 12-JAN-2017. No adverse effects reported. No product quality issues informed. This is one of two reports from the same reporter. Additional information has been requested.
Started having seizures during the day/ as opposed  to the nocturnal epilepsy I have had for 52 years. Have started blacking out/fainting for no reason.
Approximately 40 hours after 2nd Pfizer vaccine, I developed partial facial paralysis.  It became so bad the following day, I went to Urgent Care near my home.  I was afraid I was having a stroke, so did not attempt to drive to my regular doctor.  The PA on staff at UC diagnosed Bell's Palsy, and prescribed 7 days of an anti-viral plus prednisone.  I am now almost 11 weeks out from the initial diagnosis, and although I have some facial movement, full movement has not returned.  I am a professional flutist, and am devastated that I cannot form my embouchure to play my flute.
Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMG significant for Aortic systolic HF, paraoxysmal AF, dementia, acute diastolic HF, HTN, obesity, hyperlipidemia. Patient appeared at ER on 2/28/2021 with CC of SOB x 2 days. Discharged 3/2. Presented to ER 4/6 to ER. Per note on 5/6 "states that he was in his baseline state of health until January when he began experiencing a progressive decline in functional status. At baseline he was able to do all his iADLs and go for short walks in front of his house. Over the last 4 months he has had 5 admissions for worsening chest pain with exertion and worsening dyspnea with exertion managed usually as decompensated heart failure. His wife states that his DOE has progressed to the point where she is now bathing him and brushing his teeth frequently because he is too short of breath to do that. He additionally notes worsening chest pain with exertion and is having some chest discomfort with minimal exertion. During his current admission he has been treated with broad spectrum antibiotics for possible pneumonia and septic shock. He was originally bolused with IVF and then had attempted diuresis which was stopped due to collapsible IVC on bedside TTE. He was weaned of pressors and ultimately transferred to the floor yesterday. He does not note any fevers/chills/sweats/dysuria/diarrhea/productive cough leading up to his presentation. He has not had any recent surgery/invasive procedures/dental work" Patient deceased 5/7/2021.
Syncope BP 105/69 HR 97 RR 16 O2 100%.  Provided hydration and rest.  Patient stable and released from vaccination site.
Initial information received on 30 October 2014 from a healthcare provider. A 63 year old male patient with a previous history of hypertension and hyperlipidemia was vaccinated intramuscularly into the right deltoid with FLUZONE batch number UT491AB on 08 December 2014 and 12 days later on 20 December 2011, he experienced foot pain, some associated swelling and dizziness and pain in his hands after vaccination. The patient was not ill at the time of vaccination. The patient received three doses of FLUZONE in the past. Concomitant medications were not reported. The patient was seen by a neurologist on 01 Feb 2012 who continued to follow his labs. Laboratory test results and treatments were not reported. The patient states that he cannot get Flu vaccine due to GBS. The patient outcome is unknown. Documents held by sender: None.
This spontaneous report as received from a certified medical assistant refers to a pediatric patient of unknown age and gender. Medical history and drug reactions/allergies were not reported. On an unknown date, the patient was vaccinated with VAQTA, 0.5 ml, intramuscular, third dose (lot number not reported). Concomitant medication was not reported. No adverse effect reported.  This is one of several reports from the same source (1407USA011285, 1407USA011905, 1407USA011905, 1407USA011906, 1407USA011907, 1407USA011909, 1407USA011910, 1407USA011911). Additional information has been requested.
REPORTED BY MOTHER ON 2/9/10.  CHILD WAS HOSPITALIZED ON 1/8/10 WITH FEVER OVER 105 DEGREES.  FEBRILE SEIZURE AND REDNESS TO BOTH LEGS WHICH DEVELOPED POST INJECTIONS.  SPENT 2 DAYS AT HOSPITAL AND WAS RELEASED WITH ORAL ANTIBIOTIC.
This spontaneous report as received from a LPN (licensed practical nurse) refers to a 24 year old male patient. The patient medical history was unknown. It was reported that on an unknown date, the patient may have received GARDASIL. No dosing information was provided. On an unspecified date, the patient presented with condyloma (genital warts). The patient received unspecified treatment for the condyloma. The reporting nurse could not verify whether or not the patient had really received any doses of GARDASIL. The outcome of the condyloma was unknown. The reporter provided no causality assessment for GARDASIL and the condyloma. Additional information has been requested.
Bilateral PE diagnosed by CT on 5/15/21 SOB and cough started 5/8/21 diagnosed with LLL Pneumonia by CT and started on Moxifloxacin 400mg once a day. Symptoms worsened on 5/13/21 and presented to ED on 5/15/21, repeat CT performed finding bilateral PE.  Patient admitted for treatment with lovenox 60mg every 12 hours, transitioned to Eliquis 10mg upon discharge on 5/17/21
Initial unsolicited pregnancy report received from a health care professional on 14 OCTOBER 2014. A 36 years old female patient, whose medical history and concomitant medications were not reported, had received first intradermal dose of FLUZONE ID (batch number UT4992AA and expiry date 30-APR-2014) site of vaccination was not reported, on 14-OCT-2014. The patient had not experienced any adverse reaction after the first injection of FLUZONE ID. No information about prior exposure to vaccine was provided. Comments regarding the mother's health during pregnancy and risk factors (e.g.: alcohol, tobacco or recreational drugs) were reported as none. The last menstrual period was not reported and estimated date of delivery was 10 JUNE 2015. At the time of this report, the patient had not experienced any adverse events. Documents held by sender: none. Follow up information received from a nurse on 03 JUN 2015. The patient's age at the time of pregnancy was reported as 37 years. The patient had no family history of congenital abnormality. Mother's age at the time of pregnancy was 37 years. Father's age was 40 years. The patient was treated for infertility (donor egg IVF cycle and premature ovarian failure). she had tow previous pregnancies. There was 1 live birth and no pre-term birth. She  had one elective abortion. There was no spontaneous abortion prior to 20 weeks gestation and no fetal deaths (greater than 20 weeks gestation). The patient had received the following drugs during exposure: Delestrogen (20 mg/ml) from 02-SEPT-2014 to 21-NOV-2014 and ASA f5rom 02-SEP-2014 to 22-OCT-2014. She received the following drugs prior to vaccination: Lupron (5 units) from 02-SEP-2014 to 16-SEP-2014, Dexamethasone (0.5 mg) from 02-SEP-2014 to 22-SEP-2014 and Doxycycline (100mg) from 02-SEP-2014 to 08-SEP-2014. On an unspecified date, she experienced pregnancy complications which included preeclampsia (week 25-36), shortened cervix, preterm labor (week 30-31). There was no prenatal testing. The date of last menstrual period was 02-SEP-2014. Her date of delivery was 14-MAY-2015. She delivered two children (one female and one male) via cesarean section (36 weeks gestation). The heights for the male and female children were 31 cm. Weight for the male and female children were 2.63 and 2.38 kg respectfully. There were no congenital abnormalities. Documents held by sender: none.
I have been running a fever, feeling achy, and tired starting a day after the shot. Also haviny chills that will not go away.
Information has been received from a nurse concerning her son with no medical history who was vaccinated with a dose of varicella virus vaccine live. There was no concomitant medication. Subsequently, between 2-6 years he developed chicken pox. No labs were done and the patient recovered. Unspecified medical attention was sought. No product quality complaint was involved. The child's brother (WAES0601USQA03431) and sister (WAES0601USA02902) had similar experiences after vaccination with varicella virus vaccine live. Additional information has been requested.
Information has been received from a patient's mother via Internet. On an unspecified date, the patient was vaccinated with a dose of GARDASIL. The mother stated that her daughter experienced a great deal of hair loss, trouble sleeping through the night and extreme fatigue. The mother stated that she will not complete the series of GARDASIL. No further information is available.
A report has been received from a Pharmacist concerning a 54 year old, Female subject, who had been receiving Nasal FLUMIST QUADRAVALENT (INTRANASAL). FLUMIST (INTRANASAL) started on an unknown date. The pharmacist reported that WE ACCIDENTLY GAVE FLUMIST TO A 55 YEAR OLD which started on 06-Sep-2013. The outcome of the event of WE ACCIDENTLY GAVE FLUMIST TO A 55 YEAR OLD is unknown. The report was considered to be non-serious by the reporter.
Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, tenderness of neck/armpit, lymph node enlargement  Narrative:
fever; chills; nausea; reemergent fatigue; pain at injection site; fatigue; A spontaneous report was received from a consumer concerning a 76-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pain at injection site, fatigue, fever, chills, nausea and the reemergence of fatigue.  The patient's medical history was not provided. Concomitant medications reported were Allergia pill, Prolia injection, Crestor pill for drug use for unknown indication.  On unknown date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 011L20A) intramuscularly for prophylaxis of COVID-19 infection and on unknown date, the patient received their second of two planned doses of mRNA-1273 (lot/batch: 039K20A) intramuscularly for prophylaxis of COVID-19 infection.  On 8 Jan 2021, the patient experienced pain at injection site (injection site pain) and fatigue. On 5 Feb 2021, the patient experienced fever (pyrexia), chills, nausea, reemergent fatigue (fatigue).  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of events was unknown.
N17.9 - Acute kidney failure, unspecified D69.6 - Thrombocytopenia, unspecified K92.2 - Acute lower GI bleeding K92.2 - GI bleed
Fever, malaise, headache, pain at injection site....Tylenol as treatment. Resolved after 24 hours
I95.9 HYPOTENSION 2/17/2022 CHRONIC PAIN TREATMENT PLAN
Patient received Pfizer Covid-19 vaccine dose # 2 after BUD-expiration date.  Doctor recommended for dose to be repeated. patient's parents were informed of the adverse event, they reported no symptoms or signs related to this adverse event. Patient was offered to be revaccinated.
Lethargy, mentally and physically.  Depression  Isolation  Lack of motivation  Mental fog,  Extreme short term forgetfulness  Diarrhea  Weight gain
passed away; The initial case was missing the following minimum criteria: adverse event. Upon receipt of follow-up information on 01Jul2021, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable consumer (patient) and patient's wife. A 69-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6201), via an unspecified route on 10Feb2021 (at the age of 69-years) as dose 1, single and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6203), via an unspecified route on 03Mar2021 (at the age of 69-years) as dose 2, single for covid-19 immunisation. The patient medical history included Hodgkin's disease from 1978 (they took his spleen out, so he was a little immunocompromised and they took out his spleen and appendix after diagnosis) and unknown if ongoing. The patient concomitant medications were not reported. On unspecified date, the patient experienced had 3 antibody tests- one that was a 15minutes finger prick and two others that were all 2-3 weeks apart. Patient stated all 3 tests were negative for antibodies and his doctors don't know why. His doctors said maybe it did not detect antibodies to the vaccine. In 1978, he had Hodgkin's disease and they took his spleen out, so he was a little immunocompromised. However, the infectious disease doctor said since he got both doses he should still be protected. Reporter was concerned that he didn't had great immune system when three negative tests came back, he just want to make sure that everybody thinks he was not okay because he was going out over usual instructions because of them. His primary care physician (PCP) said he talked to another doctor and said if he had the vaccine it should be covered but the test came back negative. Reporter stated that the "last test he had was on 24May2021, it was COVID-19 antibody test, SARS test, COB test 2, AbIG Quantitative. This one was done on maybe 10th (unspecified date in 2021) it was rapid test for SARS, COB-2, IGg antibody. That was done on 07Apr201 and stated if Pfizer want, he can give that also, SARS, COVID, COB-2, IGgAb, AbIGm, they all came back negative". Patient's wife stated her husband passed away and at the time of the vaccination she and her daughter got adverse reactions she would like to fill the form for both her and her daughter. The patient died on unspecified date in 2021 with unknown cause of death and autopsy results was unknown. The outcome of the event was fatal. Follow up needed, further information has been requested.; Reported Cause(s) of Death: passed away
Pt was seen in the ER on 1/20/19 for a rash that had been there for two weeks, also developed fever and decreased appetite. Was given Zyrtec and Benadryl and sent home. Pt was admitted to hospital inpatient on 1/23/19, labs showed thrombocytopenia. Pt initially showed improvement and was discharged home and to have follow up with Hospital. Pt was admitted to different hospital on 1/25/19 and dx with Neutropenia and Thrombocytopenia, Granux was given, bone marrow biopsy performed and was normal. Pt was discharged with subsequent labs for follow up, all labs continued to show improvement.
Patient presented to the ED and was subsequently hospitalized with sepsis, respiratory failure and pneumonia on 3/2/2021. Patient presented to the ED and was subsequently hospitalized with pneumonia on 3/22/2021. Patient presented to the ED and was subsequently hospitalized with sepsis on 3/31/2021. He died on 4/4/2021.
2 hours after receiving the injection I starting feeling dizzy, headache, and nauseated.  The evening I had chills, sweats, headache, nausea, injection site arm was sore, and underarm pit sore.  Saturday morning broke out in hives, and under arm swollen sore extremely fatigued, and all body muscle aches.  Sunday hives changed to small red rash, still to this day have swollen and sore under left arm.  Monday red rash is going away, slight headache, fatigue, and injected arm is still sore and hurts to the touch.
Vaccine administered approx 1347 hr - pt was monitored x 25 min without adverse reaction. On call MD received call that evening from ER in which pt presented with slurred speech and vertigo and N/V. 7/25/08-records received for DOS 7/8/08-presented to ED with C/O dizziness, five hours prior had first injection of Gardasil and colposcopy for abnormal cells. After sleeping for 3 hours she felt like words were slurring drunk like and dizzy, had dry heave, right sided headache.  DX: allergic reaction to Gardasil.
p/vax & to ER w/fever & swollen & tender testicles;t102.4;had URI sx (nasal congestion), sore throat & non productive cough;PE by MD noted green nasal discharge, erythematous throat, diffuse adenopathy painful;dx viral  synd w/bacterial URI